Gomel Regional Clinical Hospital

Homyel 246029

0 studies enrolling now · 11 studies all time

What they study most

Colitis, Ulcerative, Crohn's Disease, Lupus Erythematosus, Systemic, Lupus Nephritis, Relapsing Multiple Sclerosis, Rheumatoid Arthritis, Severe Hypertriglyceridemia, Systemic Sclerosis, Ulcerative Colitis, Ulcers

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis — Completed
• Phase 2 Dose-finding IMU-838 for Ulcerative Colitis — Stopped early
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function — Completed
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment — Completed
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis — Stopped early
• Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis — Completed
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) — Completed
• Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients — Completed
• Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early